- 11:50 AM OBC a market performer, target of Rs 278: Karvy
- 11:50 AM RIL readying $25bn for global shopping: Source...
- 11:40 AM Dickens Christmas classic tops UK box office
- 11:39 AM Use upside to book profits in Educomp: Gujral
- 11:37 AM Stay invested in Educomp Solution: Mukadam
- 11:35 AM Sensex up over 150 pts; IT, metals, cap goods, pha...
- 11:32 AM Govt's GST draft positive for India: Experts
- 11:29 AM Reliance prospecting for diamonds
- 11:28 AM Neyveli Lignite has target of Rs 180-185: Gujral
- 11:25 AM NMDC, AP body to enter mining pact



TAKE Solutions announced today that its worldwide business in regulatory document management and electronic submissions software arena is making quick inroads in the Indian market. The addition of these new clients to TAKE Solutions’ globally renowned PharmaReady suite, makes this product very well entrenched in the Indian market. Amongst others, key customers in India are Ajanta Pharma, Alembic Ltd., Alkem, Dabur, Emcure Pharmaceuticals, Marksans Pharma and Serum Institute.
With esubmissions becoming mandatory in many of the countries in the West, more and more Pharma companies in India are realizing the need to update their processes and procedures to the eSubmissions platform.
With a 100% implementation and submissions success rate, PharmaReady is being put to constant use by customers in
· 12 countries
· across 4 continents
- with an install base of several thousand satisfied users
The PharmaReady suite of software distinguishes itself from the marketplace by being relevant to a wide range of global life sciences customers and prospects. This includes branded and generic bio-pharmaceutical companies in various stages of their research and application process as they seek approval from global regulatory agencies.
This success of the ParmaReady Suite can be attributed to 3 key factors:
- Extensive product range: PharmaReady suite comprises of a configurable set of modules that include Document Management System (DMS), Training and Records Management System (TRMS), Structured Product Labeling/Physician Labeling Rule (SPL/PLR) for authoring, and electronic Common Technical Document (eCTD) module for assembly and publishing of various dossiers.
- Increased functionality: PharmaReady software include a powerful new Microsoft Word plug-in authoring tool providing the most commonly required functionality for creating submission-ready documents for CTD and eCTD submissions.
- Compliance: We always been known for our versatility, flexibility and ease of use while being fully compliant with the emerging global standards of electronic submissions. The addition of the eSubmissions templates and an authoring tool makes PharmaReady a powerful software and provides a very compelling value proposition to customers and prospects.
Unlike many of its competitors, TAKE Solutions has near shore support centers located in Chennai, India for the Asia Pacific customer base that makes it very convenient for users located in this part of the world. TAKE’s offices in North America serve as the support centers for the North American and European customer base.
Talking about the company’s growth Mr. L. Ramesh, Vice President – Sales: Life Sciences – Asia Pacific & Emerging Markets, TAKE Solutions Ltd. said, “We continuously strive to add value and bring the significance and relevance of global regulatory standards to the life sciences customer base, acting as a key liaison and a thought leader in this space”.
Sourced From: Adfactors Public Relations Pvt Ltd
|
|


Today's Special Column
with Pronab Sen
Union Ministry of Statistics and Programme Implementation , Chief Statistician and Secretary


-
Most Read
-
Most Viewed
- 10 companies that MF managers love
- 10 Companies that FIIs love
- Experts on stocks and sectors to pick/avoid now

- Ganeshaspeaks: Market prediction for Nov 11
- IPO scam: SEBI bars Pyramid Saimira for 7 years

- Mitesh Thacker's top picks for today's trade

- Sensex may drift down to 12500, -ve on RIL: Shankar Sharma

- How greed got the better of this Morgan Stanley star
- Stay invested in Educomp Solution: Mukadam
Source: CNBC-TV18
- Sensex up over 150 pts; IT, metals, cap goods, pharma gain
Source: Moneycontrol.com
- Neyveli Lignite has target of Rs 180-185: Gujral
Source: CNBC-TV18
- NMDC, AP body to enter mining pact
Source: Business Line
- NMDC, AP body to enter mining pact
Source: Business Line
- Volvo-Eicher semi low-floor buses to hit the roads next yr
Source: Business Line
- Petronet likely to award LNG jetty contract next month
Source: Business Line
- NTPC units shut down on coal shortage
Source: Business Line





















